Congenital Neuromuscular Diseases Presenting in Adulthood

Seminars in Neurology

Volumn 16, Issue 1, 1996, Pages 47-54

  Suarez, Jose ^b   Cohen, Mark ^a   Kaminski, Henry J ^b,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ADENOSINE MONOPHOSPHATE DEAMINASE; ALPHA GLUCOSIDASE;

ADULT; AGED; CASE REPORT; ENZYMOLOGY; FEMALE; HUMAN; MALE; NEUROMUSCULAR DISEASE; REVIEW;

ACETYLCHOLINESTERASE; ADULT; AGED; ALPHA-GLUCOSIDASES; AMP DEAMINASE; FEMALE; HUMANS; MALE; NEUROMUSCULAR DISEASES;

EID: 0030090293     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040959     Document Type: Article

References (61)

1. Engel A. Myasthenic syndromes. In Engel A, Franzini-Armstrong C, eds. Myology. New York: McGraw-Hill, 1994:1798-835
2. Vincent A, Newsom-Davis J, Wray D, et al. Clinical and experimental observations in patients with congenital myasthenic syndromes. Ann NY Acad Sci 1993;681:451-60
3. Morgan-Hughes JA, Lecky BRF, Landon DN, Murray NMF. Alterations in the number and affinity of junctional acetylcholine receptors in a myopathy with tubular aggregates. A newly recognized receptor defect Brain 1981;104:279-95
4. Oosterhuis HJGH, Newsom-Davis J, Wokke JHJ, et al. The slow channel syndrome. Two new cases. Brain 1987; 110:1061-79
5. Engel AG. The investigation of congenital myasthenic syndromes. Ann NY Acad Sci 1993;681:425-34
6. Kaminski HJ, Ruff RL. Congenital disorders of neuromuscular transmission Hosp Pract 1992;39:73-86
7. Kaminski HJ, Ruff RL. Insights into possible skeletal muscle nicotinic acetylcholine receptor (AChR) changes in some congenital myasthenias from physiological studies, point mutations, subunit substitutions of the AChR. Ann NY Acad Sci 1993;681:435-50
8. Kaminski HJ, Ruff RL. The Myasthenic syndromes. In Schultz SG, Andreoli TE, Brown A, et al, eds. Molecular biology of membrane transport disorders. New York: Plenum Publishing (in press)
9. Engel AG, Walls TJ, Nagel A, Uchitel O. Newly recognized congenital myasthenic syndromes: I. Congenital paucity of synaptic vesicles and reduced quantal release. II.High conductance fast-channel syndrome. III. Abnormal acetylcholine receptor (AChR) interaction with acetylcholine. IV. AChR deficiency and short channel open time. Prog Brain Res 1990;84:125-37
10. Engel AG, Lambert EH, Mulder DM, et al. Investigations of 3 cases of a newly recognized familial, congenital myasthenic syndrome. Trans Am Neurol Assoc 1979;104:8-11
11. Mora M, Lambert EH, Engel AG. Synaptic vesicle abnormality in familial infantile myasthenia. Neurology 1987;37:206-14
12. Bady B, Chauplannaz G, Carrier H. Congenital Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 1987;50:476-8
13. Hutchinson DO, Engel AG, Walls TJ, et al. The spectrum of congenital end-plate acetylcholinesterase deficiency. Ann NY Acad Sci 1993;681:469-86
14. Smit LME, Hageman G, Veldman H, et al. A myasthenic syndrome with congenital paucity of secondary synaptic clefts: CPSC syndrome. Muscle Nerve 1988;11:337-48
15. Wokke JHJ, Jennekens FGI. Molenaar PC, et al. Congenital paucity of secondary synaptic clefts (CPSC) syndrome in adult sibs. Neurology 1989;39:648-54
16. Engel AG, Hutchinson DO, Nakano S, et al. Myasthenic syndromes attributed to mutations affecting the epsilon subunit of the acetylcholine receptor. Ann NY Acad Sci 1993;681:496-508
17. Kaminski HJ, Maas E, Spiegel P, Ruff RL. Why are eye muscles frequently involved by myasthenia gravis? Neurology 1990;40:1663-9
18. Sieb J, Engel A. Ephedrine: effects on neuromuscular transmission. Brain Res 1993;623:167-71
19. Karpati G, Carpenter S, Eisen A. The adult form of acid maltase (α-1,4-glucosidase) deficiency. Ann Neurol 1977;1:276-80
20. Hudgson P, Gardner-Medwin D, Worsfold M. Adult myopathy from glycogen storage disease due to acid maltase deficiency. Brain 1968;91:435-62
21. Engel A, Gomez M, Seybold ME. The spectrum and diagnosis of acid maltase deficiency. Neurology 1973;23:95-106
22. Smith J, Zellweger H, Afifi A. Muscular form of glycogenosis. type II (Pompe). Neurology 1967;17:537-49
23. Engel A, Seybold M, Lambert E. Acid maltase deficiency: comparison of infantile, childhood, and adult types. Neurology 1970;20:382
24. Hirschhorn R. Glycogen storage disease type II: acid α-glucosidase (acid maltase) deficiency. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited diseases, 7th ed. New York: McGraw-Hill, 1995:2443-64
25. Engel A, Hirschhorn R. Acid maltase deficiency. In Engel AG, Franzini-Armstrong C, eds. Myology, 2nd ed. New York-McGraw-Hill, 1994:1533-53
26. Busch H, Koster J, Weerden T. Infantile and adult-onset acid maltase deficiency occurring in the same family. Neurology 1979;31:1209-16
27. Loonen M, Busch H, Koster J. A family with different clinical forms of acid maltase deficiency (glycogenosis type II). Neurology 1981;31:1209-16
28. Engel A. Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies. Brain 1970;93:599-616
29. Scully R, Mark E, McNeeley B. Case records of the Massachusetts General Hospital. N Engl J Med 1986;315:694-701
30. Trend P, Wiles C, Spencer G. Acid maltase deficiency in adults: diagnosis and management in five cases. Brain 1985;108:845-60
31. Margolis M, Howlett P, Goldberg R. Obstructive sleep apnea syndrome in acid maltase deficiency. Chest 1994;105:947-9
32. Sivak E, Salanga V, Wilbourn A. Adult-onset acid maltase deficiency presenting as diaphragmatic paralysis. Ann Neurol 1981;9:13-5
33. Isaacs H, Savage N, Badenhorst M. Acid maltase deficiency: a case study and review of the pathophysiological changes and proposed therapeutic measures. J Neurol Neurosurg Psychiatry 1986;49:1011-8
34. Keunen R, Lambregts P, Op de Coul A. Respiratory failure as initial symptom of acid maltase deficiency. J Neurol Neurosurg Psychiatry 1984;47:549-52
35. Moufarrej N, Bertorini T. Respiratory insufficiency in adult-type acid maltase deficiency. South Med J 1993;86:560-7
36. Usuki F, Ishihiura S, Nonaka I. α-Glucosidase isoenzymes in normal and acid maltase-deficient skeletal muscles. Muscle Nerve 1988;11:365-71
37. Kuriyama M, Kohriyama T, Iwamasa T Lymphocyte α-glucosidase in late-onset glycogenosis type II. Arch Neurol 1989;46:460-2
38. Martin R, Sufit R, Ringel S. Respiratory improvement by muscle training in adult-onset acid maltase deficiency. Muscle Nerve 1983;6:201-3
39. Sabina R, Holmes E. Myoadenylate deaminase deficiency. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited diseases, 7th ed. New York: McGraw-Hill 1995:1769-80
40. Fishbein W, Armbrustmacher V, Griffin J. Myoadenylate deaminase deficiency. Science 1978;200:545-8
41. Fishbein W, Armbrustmacher V, Griffin J. Levels of adenylate deaminase, adenylate kinase and creatine kinase in frozen human muscle biopsy specimens relative to type 1/type 2 fiber distribution: evidence for a carrier state of myoadenylate deaminase deficiency. Ann Neurol 1984;15:271-7
42. Kar N, Pearson C. Muscle adenylate deaminase deficiency: report of six new cases. Arch Neurol 1981;38:279-81
43. Layzer R. Muscle pain, cramps, and fatigue. In Engel AG, Franzini-Armstrong C, eds. Myology basic and clinical, 2nd ed. New York: McGraw-Hill 1994:1754-68
44. Heller S, Kaiser K, Planer G. McArdle's disease with myoadenylate deficiency: observations in a combined enzyme deficiency. Neurology 1987;37:1039-42
45. Tonin P, Lewis P, Servidet S. Metabolic causes of myoglobinuria. Ann Neurol 1990;27:181-5
46. Sabina R, Fishbein W, Pezeshkpour G. Molecular analysis of the myoadenylate deaminase deficiencies. Neurology 1992;42:170-9
47. DiMauro S, Miranda A, Hays A. Myoadenylate deaminase deficiency: muscle biopsy and muscle culture in a patient with gout. J Neurol Sci 1980;47:191-202
48. Keleman J, Rice D, Bradley W. Familial myoadenylate deaminase deficiency and exertional myalgia. Neurology 1982;32:857-63
49. Sinkeler S, Joosten E, Wevers R. Myoadenylate deaminase deficiency: a clinical, genetic, and biochemical study in nine families. Muscle Nerve 1988;11:312-7
50. Patterson V, Kaiser K, Brooke M. Exercising muscle does not produce hypoxanthine in adenylate deaminase deficiency. Neurology 1983;12:158-9
51. Griggs R, Mendell J, Miller R. Specific myopathies. In Griggs RC, Mendell JR, Miller RG, eds. Evaluation and treatment of myopathies. Philadelphia: FA Davis, 1995:274-6
52. Patten B. Beneficial effect of D-ribose in a patient with myoadenylate deaminase deficiency. Lancet 1982;1:1071
53. Fishbein W. Myoadenylate deaminase deficiency: fact and fancy. Muscle Nerve 1989;12:158-9
54. Sinkeler S. A reply: medical reasoning in myoadenylate deaminase deficiency. Muscle Nerve 1989;12:159
55. Torbergsen T. A family with dominant hereditary myotonia, muscular hypertrophy, and increased muscular irritability, distinct from myotonia congenita Thomsen. Acta Neurol Scand 1975;51:225-32
56. Ricker K, Moxley RT III, Rohkamm R. Rippling muscle disease. Arch Neurol 1989;46:405-8
57. Stephan D, Buist N, Chittenden A, Ricker K, Zhou J, Hoffman E. A rippling muscle disease gene is localized to 1q41: evidence for multiple genes. Neurology 1994;44:1951-20
58. Ansevin C, Agamanolis D. Thymoma and myasthenia gravis with rippling muscles. Arch Neurol 1996;53:197-9
59. Kosmorksy GS, Mehta N, Mitsumoto H, Prayson R. Intermittent esotropia associated with rippling muscle disease. J Neuro-Ophthalmol 1995;15:147-51
60. Alberca R, Rafel E, Castilla J, Gil-Peralta A. Increased mechanical muscle irritability syndrome. Acta Neurol Scand 1980;62:250-4
61. Mygland A, Aarli J, Matre R, Gilhus N. Ryanodine receptor antibodies related to severity of thymoma-associated myasthenia gravis. J Neurol Neurosurg Psychiatry 1994;57:843-6